Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
29.79
+1.09 (3.80%)
At close: Sep 30, 2026, 4:00 PM EDT
29.90
+0.11 (0.37%)
Pre-market: Oct 1, 2026, 5:36 AM EDT
Hims & Hers Health Market Cap
Hims & Hers Health has a market cap or net worth of $6.95 billion as of September 30, 2026. Its market cap has decreased by -47.98% in one year.
Market Cap
6.95B
Enterprise Value
7.66B
1-Year Change
-47.98%
Ranking
Category
Stock Price
$29.79
ChartMarket Cap Chart
Since September 13, 2019, Hims & Hers Health's market cap has increased from $246.53M to $6.95B, an increase of 2,719.28%. That is a compound annual growth rate of 60.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 6.95B | -5.97% |
| Dec 31, 2025 | 7.39B | 39.92% |
| Dec 31, 2024 | 5.28B | 180.00% |
| Dec 29, 2023 | 1.89B | 41.69% |
| Dec 30, 2022 | 1.33B | -0.30% |
| Dec 31, 2021 | 1.34B | 263.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 14.42B |
| Elanco Animal Health | 11.19B |
| Dr. Reddy's Laboratories | 10.74B |
| Amneal Pharmaceuticals | 7.01B |
| Alkermes | 6.80B |
| Lantheus Holdings | 6.50B |
| Kiniksa Pharmaceuticals International, | 5.82B |
| Indivior Pharmaceuticals | 4.23B |